Deepull News and Activities

Acquisition, funding and merger involving Deepull.

• Deepull has just announced a $50 Million fundraising (posted on April 29 2025).

View the org chart displaying its 11 main executives

Most searched biographies at Deepull

• Jordi Carrera, Chief Executive Officer
• Didier Deltort, Director
• Wade Stevenson, Chief Marketing and Sales Officer

Create your alert
to follow the executive moves at Deepull.

Deepull has 2,353 competitors including Incyte (United States (USA)), Anthos Therapeutics (United States (USA)) and Valneva (France).

Popular M&A news in Biotechnology

• Renasant Bio has just announced a $54 Million fundraising (posted on July 15 2025).
• Illimis Therapeutics has just announced a $42 Million fundraising (posted on July 14 2025).
• Nuclidium has just announced a $99 Million fundraising (posted on July 14 2025).

Popular contacts in Biotechnology

• Jasbir Seehra - Chief Executive Officer and Chairman of the Board at Keros Therapeutics
• Andrea Jackson - Director at Ultivue
• Sandra Smith - Senior Vice President, Clinical Solutions & Strategic Partnerships at WIRB-Copernicus Group

Learn more about the Biotechnology industry

Press releases by Deepull

• deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection
• Deepull
• deepull receives FDA Breakthrough Device Designation for its UllCORE Bloodstream Infection Test
• deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer
• deepull appoints Didier Deltort to its Board of Directors
• deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024
• View more press releases Close

Social media about Deepull

• Deepull on Wikipedia, Google News & Yahoo Finance
• Deepull on LinkedIn, Twitter & YouTube